| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 740,200 | 685,300 | 612,000 | 698,200 | | Cost of Revenue | 505,400 | 703,000 | 497,800 | 578,100 | | | Gross Profit | 234,800 | (17,700) | 114,200 | 120,100 | | | Operating Expenses | | Research Development | 17,200 | 21,000 | 17,900 | 19,100 | | Selling General and Administrative | 178,300 | (18,600) | 79,000 | 76,400 | | Non Recurring |
-
| 1,400 | (1,600) | 385,000 | | Others | 9,700 | 9,400 | 9,200 | 9,200 | | | | Total Operating Expenses |
-
| 13,200 | 104,500 | 489,700 | | | | Operating Income or Loss | 29,600 | (30,900) | 9,700 | (369,600) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,700) | (100) | (3,200) | 2,400 | | Earnings Before Interest And Taxes | 28,100 | (30,700) | 6,700 | (367,100) | | Interest Expense | 7,600 | 5,100 | 5,600 | 7,400 | | Income Before Tax | 20,500 | (35,800) | 1,100 | (374,500) | | Income Tax Expense | 7,600 | (11,400) | 1,000 | (23,700) | | Minority Interest | (400) | (400) | (200) |
-
| | | | Net Income From Continuing Ops | 12,500 | (24,800) | (100) | (350,800) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,500 | (24,800) | (100) | (350,800) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,500 | ($24,800) | ($100) | ($350,800) |
|
1.52% Nasdaq 0.00%
Income Statement
